Evaluating URMC's Massive Transfusion Protocol
Basic Study Information
Purpose:Location: Strong Hospital at University of Rochester Medical Center
The purpose of the study is to evaluate the efficacy of the University of Rochester
Center's current Massive Transfusion Protocol.
Upon arrival of trauma level one designated patients the treating team evaluates the
patient's injuries. If the patient is initiated under the facilities Massive Transfusion
Protocol and meets other inclusion and exclusion criteria the patient will be enrolled
study. Study procedures include collection of a blood sample following the transfusion
each shipment, through shipment 5, of blood products outlined in the current Massive
Each blood sample will be run on a Thromboelastograph to evaluate the patient's hematostatic
state through resuscitation. One final blood sample will be collected 24 hours following
discontinuation of the Massive Transfusion Protocol and also ran on the thromboelastograph.
Due to the critical need for medical intervention, consent procedure will be waived
of enrollment. An authorized representative for the patient will be identified and
to obtain consent for use of data collected.
Lead Researcher (Principal Investigator)
Lead Researcher: Majed Refaai
Study Contact InformationStudy Coordinator: Annika Swanson
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search